LoginSignup
Alcon logo

Alcon

Stock
Stock
ISIN: CH0432492467
Ticker: ALC
CH0432492467
ALC

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Alcon has so far distributed $0.359 in 2026. The next dividend will be paid on 07.05.2027

$0.26

CHART BY

Frequently asked questions

The market capitalization of Alcon is $31.32B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Alcon is 51.21. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Alcon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.043. EPS indicates the company's profitability on a per-share basis.
Currently, 17 analysts cover Alcon's stock, with a consensus target price of $73.82. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Alcon reported a revenue of $8.62B.
Alcon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.96B. EBITDA measures the company's overall financial performance.
Alcon has a free cash flow of $1.37B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Alcon employs approximately 25,942 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Alcon is 481.57M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$31.32B
EPS (TTM) 
$1.043
Free Float 
481.57M
P/E ratio (TTM) 
51.21
Revenue (TTM) 
$8.62B
EBITDA (TTM) 
$1.96B
Free Cashflow (TTM) 
$1.37B

Pricing

1D span
$64.51$65.57
52W span
$61.44$88.32

Analyst Ratings

The price target is $73.82 and the stock is covered by 17 analysts.

Buy

14

Hold

2

Sell

1

Information

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Employees
25,942
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
CH0432492467
Primary Ticker
ALC

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin